These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30165429)

  • 1. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.
    Ahearn TU; Peisch S; Pettersson A; Ebot EM; Zhou CK; Graff RE; Sinnott JA; Fazli L; Judson GL; Bismar TA; Rider JR; Gerke T; Chan JM; Fiorentino M; Flavin R; Sesso HD; Finn S; Giovannucci EL; Gleave M; Loda M; Li Z; Pollak M; Mucci LA;
    Carcinogenesis; 2018 Dec; 39(12):1431-1437. PubMed ID: 30165429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.
    Mancarella C; Casanova-Salas I; Calatrava A; García-Flores M; Garofalo C; Grilli A; Rubio-Briones J; Scotlandi K; López-Guerrero JA
    BMC Cancer; 2017 May; 17(1):367. PubMed ID: 28545426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1.
    Meisel Sharon S; Pozniak Y; Geiger T; Werner H
    Oncotarget; 2016 Aug; 7(32):51375-51392. PubMed ID: 27285981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
    Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
    Eur Urol; 2019 Jul; 76(1):33-40. PubMed ID: 30301696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion.
    Gerashchenko GV; Mevs LV; Chashchina LI; Pikul MV; Gryzodub OP; Stakhovsky EO; Kashuba VI
    Exp Oncol; 2018 Jun; 40(2):101-108. PubMed ID: 29949537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
    Ahearn TU; Pettersson A; Ebot EM; Gerke T; Graff RE; Morais CL; Hicks JL; Wilson KM; Rider JR; Sesso HD; Fiorentino M; Flavin R; Finn S; Giovannucci EL; Loda M; Stampfer MJ; De Marzo AM; Mucci LA; Lotan TL
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26615022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage.
    Aleksic T; Gray N; Wu X; Rieunier G; Osher E; Mills J; Verrill C; Bryant RJ; Han C; Hutchinson K; Lambert AG; Kumar R; Hamdy FC; Weyer-Czernilofsky U; Sanderson MP; Bogenrieder T; Taylor S; Macaulay VM
    Cancer Res; 2018 Jul; 78(13):3497-3509. PubMed ID: 29735545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.
    Vaquero J; Lobe C; Tahraoui S; Clapéron A; Mergey M; Merabtene F; Wendum D; Coulouarn C; Housset C; Desbois-Mouthon C; Praz F; Fouassier L
    Clin Cancer Res; 2018 Sep; 24(17):4282-4296. PubMed ID: 29716918
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
    Pettersson A; Lis RT; Meisner A; Flavin R; Stack EC; Fiorentino M; Finn S; Graff RE; Penney KL; Rider JR; Nuttall EJ; Martin NE; Sesso HD; Pollak M; Stampfer MJ; Kantoff PW; Giovannucci EL; Loda M; Mucci LA
    J Natl Cancer Inst; 2013 Dec; 105(24):1881-90. PubMed ID: 24292212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
    Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
    Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.
    Yamoah K; Lal P; Awasthi S; Naghavi AO; Rounbehler RJ; Gerke T; Berglund AE; Pow-Sang JM; Schaeffer EM; Dhillon J; Park JY; Rebbeck TR
    Prostate; 2021 Feb; 81(2):109-117. PubMed ID: 33141952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
    Graff RE; Pettersson A; Lis RT; DuPre N; Jordahl KM; Nuttall E; Rider JR; Fiorentino M; Sesso HD; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Nguyen PL; Sweeney CJ; Mucci LA;
    Prostate; 2015 Jun; 75(9):897-906. PubMed ID: 25728532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.
    Zeng W; Sun H; Meng F; Liu Z; Xiong J; Zhou S; Li F; Hu J; Hu Z; Liu Z
    Int J Clin Exp Pathol; 2015; 8(2):1878-88. PubMed ID: 25973080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells.
    Zhou F; Gao S; Han D; Han W; Chen S; Patalano S; Macoska JA; He HH; Cai C
    Oncogene; 2019 May; 38(22):4397-4411. PubMed ID: 30718921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
    Wang Z; Wang Y; Zhang J; Hu Q; Zhi F; Zhang S; Mao D; Zhang Y; Liang H
    Mol Med Rep; 2017 Oct; 16(4):5450-5458. PubMed ID: 28849022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.
    Zu K; Martin NE; Fiorentino M; Flavin R; Lis RT; Sinnott JA; Finn S; Penney KL; Ma J; Fazli L; Gleave ME; Bismar TA; Stampfer MJ; Pollak MN; Loda M; Mucci LA; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1984-93. PubMed ID: 23983239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.
    Berg KD
    Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.
    Mancarella C; Casanova-Salas I; Calatrava A; Ventura S; Garofalo C; Rubio-Briones J; Magistroni V; Manara MC; López-Guerrero JA; Scotlandi K
    Oncotarget; 2015 Jun; 6(18):16611-22. PubMed ID: 25906745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer.
    Allott EH; Ebot EM; Stopsack KH; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Ahearn TU; Gerke TA; Downer MK; Rider JR; Freedland SJ; Lotan TL; Kantoff PW; Platz EA; Loda M; Stampfer MJ; Giovannucci E; Sweeney CJ; Finn SP; Mucci LA
    Clin Cancer Res; 2020 Mar; 26(5):1086-1093. PubMed ID: 31754047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.